BP8 Advances Indonesian Seaweed Sales with Second Major Shipment

BPH Global Ltd has completed its second seaweed sale under a strategic partnership in Indonesia, marking steady progress in its supply network expansion and operational execution.

  • Second seaweed sale completed under Sales Cooperation Agreement with PT Kebula Raya Bestari
  • 40 metric tonnes of seaweed biomass sold to PT Surya Seaweed Indonesia for USD 39,370
  • Logistics and supply chain managed by Kebula leveraging local networks
  • Profit sharing arrangement set at 65% to BP8 and 35% to Kebula
  • Follows initial sale to South Korean buyer MSC Ltd, reinforcing growth momentum
An image related to BPH GLOBAL LTD
Image source middle. ©

Strategic Partnership Gains Traction

BPH Global Ltd (ASX, BP8) has announced the completion of its second seaweed sale under a Sales Cooperation Agreement with Indonesian partner PT Kebula Raya Bestari. This milestone underscores the practical progress of BP8's strategy to deepen its footprint in the Indonesian seaweed market, a region known for its rich marine resources and growing demand for seaweed-derived products.

The recent transaction involved the sale of 40 metric tonnes of Indonesian seaweed biomass to PT Surya Seaweed Indonesia, a local intermediary specializing in supplying carrageenan producers. The deal was valued at USD 39,370, inclusive of Indonesian value-added tax, and was facilitated end-to-end by Kebula, which managed logistics and supply chain arrangements leveraging its established network.

Operational Execution and Profit Sharing

BP8’s Managing Director, Matthew Leonard, highlighted the significance of Kebula’s role in enabling efficient connections between Indonesian producers and both domestic and international buyers. The partnership model includes a profit-sharing arrangement, with BP8 receiving 65% of proceeds and Kebula 35%, reflecting the collaborative nature of the venture and the value Kebula adds through its operational expertise.

This second sale follows an initial shipment to MSC Ltd, a South Korean food ingredient manufacturer, announced in late May 2025. Together, these transactions demonstrate BP8’s ability to execute on its sales cooperation framework and build a scalable supply chain in a competitive sector.

Market Context and Future Outlook

Indonesia’s seaweed industry is a vital part of the global supply chain for carrageenan and other seaweed-based products, which are increasingly sought after for food, pharmaceutical, and cosmetic applications. BP8’s approach of partnering with local entities like Kebula allows it to navigate the complexities of regional logistics and regulatory environments while tapping into established supplier networks.

While the current sales volumes remain modest, the successful completion of consecutive shipments signals growing operational momentum. Investors will be watching closely to see how BP8 scales these efforts, diversifies its customer base, and manages margins within the profit-sharing framework.

Bottom Line?

BP8’s steady progress in Indonesian seaweed sales sets the stage for potential scale-up, but future growth hinges on expanding volumes and customer reach.

Questions in the middle?

  • How quickly can BP8 increase seaweed sales volumes beyond current modest levels?
  • Will BP8 seek to diversify its customer base beyond intermediaries like PT Surya Seaweed Indonesia?
  • How sustainable and profitable is the current 65, 35 profit-sharing model as operations scale?